X4 Pharmaceuticals Inc (NASDAQ:XFOR)

2.22
Delayed Data
As of 3:59pm ET
 +0.19 / +9.36%
Today’s Change
0.65
Today|||52-Week Range
2.41
+123.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$249.3M

Company Description

X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Contact Information

X4 Pharmaceuticals, Inc.
61 North Beacon Street
Boston Massachusetts 02134
P:(857) 529-8300
Investor Relations:

Employees

Shareholders

Other institutional22.51%
Mutual fund holders10.23%
Individual stakeholders1.20%

Top Executives

Paula S. RaganPresident, Chief Executive Officer & Director
Mary DiBiaseChief Operating Officer
Adam S. MostafaChief Financial Officer, Secretary & Treasurer
Murray Willis StewartDirector & Chief Medical Officer
Art TaverasChief Scientific Officer